However, PPARα was downregulated in patients with NASH compared to both patients with steatosis and healthy controls [124,125], and the expression of PPARα decreases with increasing NAFLD activity score and progression of fibrosis [124]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.